Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	5 Milligram (mg) Tirzepatide	47
Overall Study	STARTED	10 mg Tirzepatide	47
Overall Study	STARTED	15 mg Tirzepatide	48
Overall Study	STARTED	Placebo	48
Overall Study	Received at Least One Dose of Study Drug	5 Milligram (mg) Tirzepatide	47
Overall Study	Received at Least One Dose of Study Drug	10 mg Tirzepatide	47
Overall Study	Received at Least One Dose of Study Drug	15 mg Tirzepatide	48
Overall Study	Received at Least One Dose of Study Drug	Placebo	48
Overall Study	COMPLETED	5 Milligram (mg) Tirzepatide	40
Overall Study	COMPLETED	10 mg Tirzepatide	44
Overall Study	COMPLETED	15 mg Tirzepatide	43
Overall Study	COMPLETED	Placebo	38
Overall Study	NOT COMPLETED	5 Milligram (mg) Tirzepatide	7
Overall Study	NOT COMPLETED	10 mg Tirzepatide	3
Overall Study	NOT COMPLETED	15 mg Tirzepatide	5
Overall Study	NOT COMPLETED	Placebo	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04166773/flow